143 related articles for article (PubMed ID: 16912659)
1. Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained.
Nogueira AA; Sant'Ana de Almeida EC; Poli Neto OB; Zambelli Ramalho LN; Rosa e Silva JC; Candido dos Reis FJ
Menopause; 2006; 13(5):826-30. PubMed ID: 16912659
[TBL] [Abstract][Full Text] [Related]
2. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63.
O'Connell JT; Mutter GL; Cviko A; Nucci M; Quade BJ; Kozakewich HP; Neffen E; Sun D; Yang A; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):30-6. PubMed ID: 11136566
[TBL] [Abstract][Full Text] [Related]
3. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
Xuebing P; TinChiu L; Enlan X; Jing L; Xiaowu H
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):198-203. PubMed ID: 21726930
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
5. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
7. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index.
Belisário MS; Vassallo J; Andrade LA; Alvarenga M; Pinto GA; Monteiro IM
Maturitas; 2006 Jan; 53(1):114-8. PubMed ID: 15894442
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune environment in endometrial polyps.
El-Hamarneh T; Hey-Cunningham AJ; Berbic M; Al-Jefout M; Fraser IS; Black K
Fertil Steril; 2013 Nov; 100(5):1364-72. PubMed ID: 23931965
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
10. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
11. Endometrial polyps in infertile patients: do high concentrations of interferon-gamma play a role?
Mollo A; Stile A; Alviggi C; Granata M; De Placido G; Perrella A; d'Antonio A; Cicinelli E
Fertil Steril; 2011 Nov; 96(5):1209-12. PubMed ID: 21872231
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
[TBL] [Abstract][Full Text] [Related]
13. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
14. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
15. The malignant potential of endometrial polyps.
Ben-Arie A; Goldchmit C; Laviv Y; Levy R; Caspi B; Huszar M; Dgani R; Hagay Z
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):206-10. PubMed ID: 15262357
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
[TBL] [Abstract][Full Text] [Related]
17. Location of endometrial polyp and pregnancy rate in infertility patients.
Yanaihara A; Yorimitsu T; Motoyama H; Iwasaki S; Kawamura T
Fertil Steril; 2008 Jul; 90(1):180-2. PubMed ID: 17889854
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopic polypectomy decreases NF-κB1 expression in the mid-secretory endometrium of women with endometrial polyp.
Bozkurt M; Şahin L; Ulaş M
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():96-100. PubMed ID: 25898371
[TBL] [Abstract][Full Text] [Related]
19. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
20. Are the site, diameter, and number of endometrial polyps related with symptomatology?
Hassa H; Tekin B; Senses T; Kaya M; Karatas A
Am J Obstet Gynecol; 2006 Mar; 194(3):718-21. PubMed ID: 16522403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
